{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:22:22Z","timestamp":1707524542846},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,7]]},"DOI":"10.7759\/cureus.24812","type":"journal-article","created":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T20:07:11Z","timestamp":1651954031000},"source":"Crossref","is-referenced-by-count":0,"title":["A Rare Case of Creutzfeldt\u2013Jakob Disease With Alcohol Use Disorder and Review of Literature"],"prefix":"10.7759","author":[{"given":"Abraham","family":"Joseph","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisham","family":"Mushtaq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Zakhia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Rohde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adria","family":"Whiting","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbas B","family":"Jama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anwar","family":"Khedr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nitesh K","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Anjum","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(20)30477-4","article-title":"Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease","volume":"20","author":"Hermann P","year":"2021","unstructured":"Hermann P, Appleby B, Brandel JP, et al.. Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease. Lancet Neurol. 2021, 20:235-46. 10.1016\/S1474-4422(20)30477-4","journal-title":"Lancet Neurol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-1687841","article-title":"Prion disease","volume":"39","author":"Baldwin KJ","year":"2019","unstructured":"Baldwin KJ, Correll CM. Prion disease. Semin Neurol. 2019, 39:428-39. 10.1055\/s-0039-1687841","journal-title":"Semin Neurol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1212\/CON.0000000000000319","article-title":"Rapidly progressive dementia","volume":"22","author":"Geschwind MD","year":"2016","unstructured":"Geschwind MD. Rapidly progressive dementia. Continuum (Minneap Minn). 2016, 22:510-37. 10.1212\/CON.0000000000000319","journal-title":"Continuum (Minneap Minn)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.62.4.545","article-title":"Human prion diseases: molecular and clinical aspects","volume":"62","author":"Glatzel M","year":"2005","unstructured":"Glatzel M, Stoeck K, Seeger H, L\u00fchrs T, Aguzzi A. Human prion diseases: molecular and clinical aspects. Arch Neurol. 2005, 62:545-52. 10.1001\/archneur.62.4.545","journal-title":"Arch Neurol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awh249","article-title":"Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies","volume":"127","author":"Pocchiari M","year":"2004","unstructured":"Pocchiari M, Puopolo M, Croes EA, et al.. Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Brain. 2004, 127:2348-59. 10.1093\/brain\/awh249","journal-title":"Brain"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awm063","article-title":"Creutzfeldt-Jakob disease in Germany: a prospective 12-year surveillance","volume":"130","author":"Heinemann U","year":"2007","unstructured":"Heinemann U, Krasnianski A, Meissner B, et al.. Creutzfeldt-Jakob disease in Germany: a prospective 12-year surveillance. Brain. 2007, 130:1350-9. 10.1093\/brain\/awm063","journal-title":"Brain"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410050212","article-title":"Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering","volume":"5","author":"Masters CL","year":"1979","unstructured":"Masters CL, Harris JO, Gajdusek DC, Gibbs CJ Jr, Bernoulli C, Asher DM. Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering. Ann Neurol. 1979, 5:177-88. 10.1002\/ana.410050212","journal-title":"Ann Neurol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.37.6.895","article-title":"The epidemiology of Creutzfeldt-Jakob disease: conclusion of a 15-year investigation in France and review of the world literature","volume":"37","author":"Brown P","year":"1987","unstructured":"Brown P, Cathala F, Raubertas RF, Gajdusek DC, Castaigne P. The epidemiology of Creutzfeldt-Jakob disease: conclusion of a 15-year investigation in France and review of the world literature. Neurology. 1987, 37:895-904. 10.1212\/wnl.37.6.895","journal-title":"Neurology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.73.863.557","article-title":"Creutzfeldt-Jakob disease in the elderly","volume":"73","author":"de Silva R","year":"1997","unstructured":"de Silva R, Findlay C, Awad I, Harries-Jones R, Knight R, Will R. Creutzfeldt-Jakob disease in the elderly. Postgrad Med J. 1997, 73:557-9. 10.1136\/pgmj.73.863.557","journal-title":"Postgrad Med J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1017\/s0317167100027542","article-title":"Jakob-Creutzfeldt disease associated with Wernicke encephalopathy","volume":"15","author":"Gaytan-Garcia S","year":"1988","unstructured":"Gaytan-Garcia S, Gilbert JJ, Deck JH, Kaufmann JC. Jakob-Creutzfeldt disease associated with Wernicke encephalopathy. Can J Neurol Sci. 1988, 15:156-60. 10.1017\/s0317167100027542","journal-title":"Can J Neurol Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510x(92)90045-m","article-title":"Creutzfeldt-Jakob disease presenting as Wernicke-Korsakoff syndrome","volume":"108","author":"Pietrini V","year":"1992","unstructured":"Pietrini V. Creutzfeldt-Jakob disease presenting as Wernicke-Korsakoff syndrome. J Neurol Sci. 1992, 108:149-53. 10.1016\/0022-510x(92)90045-m","journal-title":"J Neurol Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-510x(99)00035-0","article-title":"Wernicke encephalopathy-like symptoms as an early manifestation of Creutzfeldt-Jakob disease in a chronic alcoholic","volume":"163","author":"Nagashima T","year":"1999","unstructured":"Nagashima T, Okawa M, Kitamoto T, Takahashi H, Ishihara Y, Ozaki Y, Nagashima K. Wernicke encephalopathy-like symptoms as an early manifestation of Creutzfeldt-Jakob disease in a chronic alcoholic. J Neurol Sci. 1999, 163:192-8. 10.1016\/s0022-510x(99)00035-0","journal-title":"J Neurol Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2007.05.022","article-title":"Wernicke's encephalopathy mimicking variant Creutzfeldt-Jakob disease","volume":"15","author":"Stone R","year":"2008","unstructured":"Stone R, Archer JS, Kiernan M. Wernicke's encephalopathy mimicking variant Creutzfeldt-Jakob disease. J Clin Neurosci. 2008, 15:1308-10. 10.1016\/j.jocn.2007.05.022","journal-title":"J Clin Neurosci"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1212\/CPJ.0000000000000111","article-title":"Comparing CSF biomarkers and brain MRI in the diagnosis of sporadic Creutzfeldt-Jakob disease","volume":"5","author":"Forner SA","year":"2015","unstructured":"Forner SA, Takada LT, Bettcher BM, et al.. Comparing CSF biomarkers and brain MRI in the diagnosis of sporadic Creutzfeldt-Jakob disease. Neurol Clin Pract. 2015, 5:116-25. 10.1212\/CPJ.0000000000000111","journal-title":"Neurol Clin Pract"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2020.1319","article-title":"Evaluation of a new criterion for detecting prion disease with diffusion magnetic resonance imaging","volume":"77","author":"Bizzi A","year":"2020","unstructured":"Bizzi A, Pascuzzo R, Blevins J, et al.. Evaluation of a new criterion for detecting prion disease with diffusion magnetic resonance imaging. JAMA Neurol. 2020, 77:1141-9. 10.1001\/jamaneurol.2020.1319","journal-title":"JAMA Neurol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2294","article-title":"Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion","volume":"17","author":"Atarashi R","year":"2011","unstructured":"Atarashi R, Satoh K, Sano K, et al.. Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion. Nat Med. 2011, 17:175-8. 10.1038\/nm.2294","journal-title":"Nat Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/ana.23589","article-title":"Real time quaking-induced conversion analysis of cerebrospinal fluid in sporadic Creutzfeldt-Jakob disease","volume":"72","author":"McGuire LI","year":"2012","unstructured":"McGuire LI, Peden AH, Orr\u00fa CD, et al.. Real time quaking-induced conversion analysis of cerebrospinal fluid in sporadic Creutzfeldt-Jakob disease. Ann Neurol. 2012, 72:278-85. 10.1002\/ana.23589","journal-title":"Ann Neurol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1315200","article-title":"A test for Creutzfeldt-Jakob disease using nasal brushings","volume":"371","author":"Orr\u00fa CD","year":"2014","unstructured":"Orr\u00fa CD, Bongianni M, Tonoli G, et al.. A test for Creutzfeldt-Jakob disease using nasal brushings. N Engl J Med. 2014, 371:519-29. 10.1056\/NEJMoa1315200","journal-title":"N Engl J Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aam7785","article-title":"Prion seeding activity and infectivity in skin samples from patients with sporadic Creutzfeldt-Jakob disease","volume":"9","author":"Orr\u00fa CD","year":"2017","unstructured":"Orr\u00fa CD, Yuan J, Appleby BS, et al.. Prion seeding activity and infectivity in skin samples from patients with sporadic Creutzfeldt-Jakob disease. Sci Transl Med. 2017, 9:10.1126\/scitranslmed.aam7785","journal-title":"Sci Transl Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02095-18","article-title":"Prion seeds distribute throughout the eyes of sporadic Creutzfeldt-Jakob disease patients","volume":"9","author":"Orr\u00f9 CD","year":"2018","unstructured":"Orr\u00f9 CD, Soldau K, Cordano C, et al.. Prion seeds distribute throughout the eyes of sporadic Creutzfeldt-Jakob disease patients. mBio. 2018, 9:10.1128\/mBio.02095-18","journal-title":"mBio"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24833","article-title":"Diagnostic and prognostic value of human prion detection in cerebrospinal fluid","volume":"81","author":"Foutz A","year":"2017","unstructured":"Foutz A, Appleby BS, Hamlin C, et al.. Diagnostic and prognostic value of human prion detection in cerebrospinal fluid. Ann Neurol. 2017, 81:79-92. 10.1002\/ana.24833","journal-title":"Ann Neurol"},{"key":"ref22","unstructured":"CDC\u2019s diagnostic criteria for Creutzfeldt-Jakob disease (CJD), 2018. (2018). Accessed. April 20, 2022: https:\/\/www.cdc.gov\/prions\/cjd\/diagnostic-criteria.html."},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000308955.25760.c2","article-title":"Systematic review of therapeutic interventions in human prion disease","volume":"70","author":"Stewart LA","year":"2008","unstructured":"Stewart LA, Rydzewska LH, Keogh GF, Knight RS. Systematic review of therapeutic interventions in human prion disease. Neurology. 2008, 70:1272-81. 10.1212\/01.wnl.0000308955.25760.c2","journal-title":"Neurology"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-63945-5.00021-0","article-title":"Symptomatic treatment, care, and support of CJD patients","volume":"153","author":"Appleby BS","year":"2018","unstructured":"Appleby BS, Yobs DR. Symptomatic treatment, care, and support of CJD patients. Handb Clin Neurol. 2018, 153:399-408. 10.1016\/B978-0-444-63945-5.00021-0","journal-title":"Handb Clin Neurol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1006\/exnr.1997.6559","article-title":"Effect of flupirtine on Bcl-2 and glutathione level in neuronal cells treated in vitro with the prion protein fragment (PrP106-126)","volume":"147","author":"Perovic S","year":"1997","unstructured":"Perovic S, Schr\u00f6der HC, Pergande G, Ushijima H, M\u00fcller WE. Effect of flupirtine on Bcl-2 and glutathione level in neuronal cells treated in vitro with the prion protein fragment (PrP106-126). Exp Neurol. 1997, 147:518-24. 10.1006\/exnr.1997.6559","journal-title":"Exp Neurol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2008.02108.x","article-title":"Intraventricular pentosan polysulphate in human prion diseases: an observational study in the UK","volume":"15","author":"Bone I","year":"2008","unstructured":"Bone I, Belton L, Walker AS, Darbyshire J. Intraventricular pentosan polysulphate in human prion diseases: an observational study in the UK. Eur J Neurol. 2008, 15:458-64. 10.1111\/j.1468-1331.2008.02108.x","journal-title":"Eur J Neurol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.161274798","article-title":"Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease","volume":"98","author":"Korth C","year":"2001","unstructured":"Korth C, May BC, Cohen FE, Prusiner SB. Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease. Proc Natl Acad Sci U S A. 2001, 98:9836-41. 10.1073\/pnas.161274798","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.2174\/1871526510909010023","article-title":"Tetracyclines and prion infectivity","volume":"9","author":"Forloni G","year":"2009","unstructured":"Forloni G, Salmona M, Marcon G, Tagliavini F. Tetracyclines and prion infectivity. Infect Disord Drug Targets. 2009, 9:23-30. 10.2174\/1871526510909010023","journal-title":"Infect Disord Drug Targets"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/96494-a-rare-case-of-creutzfeldt-jakob-disease-with-alcohol-use-disorder-and-review-of-literature","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:42:02Z","timestamp":1707507722000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/96494-a-rare-case-of-creutzfeldt-jakob-disease-with-alcohol-use-disorder-and-review-of-literature"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,7]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.24812","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5,7]]}}}